Attached files
file | filename |
---|---|
EX-99.1 - SLIDE PRESENTATION - Fortress Biotech, Inc. | d405471dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act 1934
Date of Report (Date of earliest event reported): September 4, 2012
Coronado Biosciences, Inc.
(Exact name of registrant as specified in charter)
Delaware | 001-35366 | 20-5157386 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
15 New England Executive Park, Burlington, MA |
01803 | |||
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (781) 238-6621
(Former Name or Former Address, is Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b)) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. Regulation FD Disclosures.
On September 5, 2012, executives of Coronado Biosciences, Inc. (the Company) will make a presentation about the Company to certain analysts and investors at the Stifel Niclolaus 2012 Healthcare Conference in Boston, Massachusetts. A copy of the slide presentation is furnished as exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) | Exhibits |
Exhibit |
Description | |
99.1 | September 5, 2012 Slide Presentation |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, we have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CORONADO BIOSCIENCES, INC. | ||||||
By: | /s/ Lucy Lu | |||||
Name: Lucy Lu | ||||||
Title: Chief Financial Officer |
Dated: September 4, 2012
EXHIBIT INDEX
Exhibit |
Description | |
99.1 | September 5, 2012 Slide Presentation |